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How do women experience a false-positive test result from
breast screening? A systematic review and thematic
synthesis of qualitative studies
Hannah Long 1, Joanna M. Brooks1, Michelle Harvie 2, Anthony Maxwell 2,3 and David P. French 1
BACKGROUND: This is the first review to identify, appraise and synthesise women’s experiences of having a false-positive breast
screening test result.
METHODS:We systematically searched eight databases for qualitative research reporting women’s experiences of receiving a false-
positive screening test result. Two reviewers independently screened articles. Eight papers reporting seven studies were included.
Study quality was appraised. Data were thematically synthesised.
RESULTS: Women passively attended screening in order to prove their perceived good health. Consequently, being recalled was
unexpected, shocking and disempowering: women felt without options. They endured great uncertainty and stress and sought
clarity about their health (e.g. by scrutinising the wording of recall letters and conversations with healthcare professionals). Their
result was accompanied by relief and welcome feelings of certainty about their health, but some received unclear explanations of
their result, contributing to lasting breast cancer-related worry and an ongoing need for further reassurance.
CONCLUSION: The organisation of breast screening programmes may constrain choice for women: they became passive recipients.
The way healthcare professionals verbally communicate results to women may contribute to lasting breast cancer-related worry.
Women need more reassurance, emotional support and answers to their questions before and during screening assessment, and
after receiving their result.
British Journal of Cancer (2019) 121:351–358; https://doi.org/10.1038/s41416-019-0524-4
BACKGROUND
Breast screening aims to detect and treat early-stage cancer in
women, when treatment is less severe and more likely to be
successful than for later-stage cancers.1 Screening has the
potential to reduce breast cancer mortality, but it is also
associated with unintended harms, such as overdiagnosis, over-
treatment, false-negative and false-positive screening test
results.1,2 A false-positive screening test result is said to be
present when an initial screening mammogram indicates an
abnormality, necessitating further diagnostic tests, which indicate
cancer is not present.3 Under the National Health Service Breast
Screening Programme (NHS BSP) in England, 2.2 million women
were screened in the 2016–2017 screening period and over 70,000
of them received a false-positive screening test result.4
The experience of being recalled and receiving a false-positive
screening test result can be distressing for many women.5–9
However, the nature of this experience and any psychological
impact is not well understood. Systematic reviews have quantified
the impact of false-positive screening test results on the women
who receive them, but they paint a complex picture with much
conflicting evidence.2,6,9–12 It is clear that having a false-positive
screening test result can lead to short-term breast cancer-related
worry, compared to women with normal screening results.6,9 One
study reported evidence of longer-term breast cancer-related
worry at 3 years,13 but others have observed that worry abates
over time.14,15 The evidence suggests that having a false-positive
screening test result does not lead to clinical levels of depression
or anxiety.6,9,16 The impact of receiving a false-positive screening
test result on the likelihood of returning for the next routine
screening is inconsistent.6,10,12 Both the degree of worry and the
likelihood of re-attending have been found to be related to the
procedures performed when women are recalled for further
investigations (a process known as screening assessment). The
more invasive procedures, such as needle biopsy, are associated
with greater worry and less chance of re-attending the next
routine screening appointment.13,17–19
There are no peer-reviewed systematic reviews that have
included qualitative research of women’s experiences of receiving
a false-positive screening test result. One systematic review of
qualitative research included both false-positive and false-
negative screening test results.20 However, this review was not
published in a peer-reviewed journal. Further, the review authors
did not independently assess the quality of included studies.
Cochrane consider quality appraisal to be an essential step in
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qualitative evidence synthesis, particularly if the findings are to be
used to inform subsequent practice and research.21 The review
found that women who had received false-positive screening test
results described feelings of fear and breast cancer-related worry,
but were undeterred from future screening. Appropriately, the
review authors did not make any practice or research recommen-
dations (e.g. how to reduce the negative impact for women with
inaccurate screening results or progress research in this area), but
as a result the review’s utility is limited.
Given the inconsistent findings from systematic reviews of
quantitative research and the lack of a robust qualitative evidence
synthesis, a better understanding of the experience of having a
false-positive breast screening test result is needed. Systematic
reviews of qualitative studies capture people’s beliefs, perspec-
tives and experiences in both depth (through the qualitative
approach) and also breadth (through the integration of studies
across different contexts and populations). They offer novel and
more comprehensive understanding of phenomena and are
increasingly recognised as important in evidence-based deci-
sion-making for healthcare and policy.22–24
The present review aimed to synthesise women’s experiences of
receiving a false-positive breast screening test result. The specific
objectives of this review were to (i) systematically identify and
appraise existing qualitative research on the experiences, views,
and beliefs of women who have received a false-positive
screening test result, (ii) use thematic synthesis to synthesise the
findings of relevant qualitative research, and (iii) identify directions
for future research to improve women’s experiences of having a
false-positive screening test result.
METHODS
This systematic review was registered on PROSPERO
(CRD42017083404) and is reported according to the PRISMA
(Supplementary Materials 1) and ENTREQ statements (Supple-
mentary Materials 2).23,25
Search strategy and eligibility criteria
The following electronic databases were searched: CINAHL,
EMBASE, MEDLINE, PsycINFO (each up to 23 January 2018), Web
of Science conference proceedings and book citations (up to 5
February 2018), Dissertations Abstracts International, NHS Evi-
dence and Open Grey (each up to 6 February 2018). The ‘Context,
How, Issue, Population’ (CHIP) tool was used to formulate the
search terms.26 The search strategy was designed to be
comprehensive and to seek all available studies. The strategy
was tailored to the specific indexing language of each database
and used medical subject headings (MeSH), other index terms,
keywords and appropriate synonyms (Supplementary Materials 3).
Search terms were also based on the search strategy of a
systematic review of UK-based, quantitative studies on this topic,
which had included search terms for qualitative studies.6
Databases were searched from 1970 as breast screening for
cancer was introduced to Western healthcare systems in the early
1970s. Forward and backward citation searches and hand-
searching of the reference lists were conducted for all included
papers. EndNote was used to manage retrieved articles.
The first author screened all titles and/or abstracts and a second
reviewer screened 30% (k= 1503) of these (99% agreement). The
first author read the full texts of all potentially eligible articles and
assessed these against the eligibility criteria (Table 1). A second
reviewer read the full texts of 50% (k= 11) of these and, following
discussion, agreement between the two reviewers was reached.
Quality appraisal
Study quality was assessed using a modified Critical Appraisal
Skills Programme (CASP) tool for qualitative research.27 Two
papers reported one study, and these were appraised separately
as they answered different research questions. Adequately
reporting one’s approach to inquiry has been recognised as an
indicator of methodological quality in qualitative primary
studies,28 but the original CASP tool does not have an item
related to this. Therefore, the research team included an
additional question: ‘are the study’s theoretical underpinnings
(e.g. ontological and epistemological assumptions; guiding
theoretical framework(s)) clear, consistent and conceptually
coherent?’. A fourth response—‘somewhat’—was added for
questions answered ‘yes’, ‘no’, or ‘can’t tell’, to indicate when a
criterion had been partially addressed but lacked some key
elements.
The first author independently appraised the quality of all
included studies. Following this, a second and third reviewer
independently appraised the quality of one study each (k= 2;
25%) and these decisions were discussed in-team. This process
facilitated piloting of the additional question and checked the
reliability of quality appraisal decisions. In the synthesis, greater
weight was given to findings of studies determined to be of
higher quality. The quality appraisal results did not determine
study inclusion.
Data extraction
A standardised data extraction sheet was used to extract
research aims, country of origin, sample size, data collection
method and data analysis method. The data to be synthesised
were the primary study authors’ interpretations of their study
findings and all direct quotations from participants. As per
Thomas and Harden’s guidelines for thematic synthesis,29
all text contained beneath the article heading ‘results’ or
‘findings’ was treated as data, and any findings reported in the
abstract.
Data synthesis
This review followed Thomas and Harden’s method of thematic
synthesis.29 The first author (a PhD student researcher with a
health psychology background) read the full set of papers several
times. Two other authors (experienced researchers with expertise
in health psychology, cancer screening and qualitative methods)
each read a different half of the set of papers. The present
approach to inquiry was informed by dialectical pluralism.
This approach allows for work undertaken from multiple and
often competing paradigms (and underpinned by differing
epistemological and ontological assumptions) to be combined
into a new, agreed upon whole.30
Table 1. Eligibility criteria
Inclusion criteria
(a) Qualitative methodology (i.e. data collection and analysis).
(b) Adult women (aged 18+ years) who have received a false-positive
breast screening test result or an abnormal breast screening
test result (and are awaiting screening assessment or the associated
results).
(c) Mixed samples of adults screened for, or diagnosed with, other
cancer types only if it is possible to separately identify those
findings related to having a false-positive breast screening
test result.
(d) Any country.
(e) Published in English.
Exclusion criteria
(f ) Study findings could not be separated in criterion (c).
(g) The sample was all diagnosed with breast cancer (invasive and
ductal carcinoma in situ).
(h) Individual case studies.
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Data analysis involved three main stages. First, the first author
undertook inductive line-by-line coding of the primary study
findings, with regular discussion with other authors. Participant
quotations were coded initially (i.e. first-order codes), followed by
the primary authors’ narrative and interpretations (i.e. second-
order codes). During coding, each line of text is assigned one or
more codes that summarises its context and meaning. A
preliminary list of codes was developed based on the findings
of the highest quality studies. These codes were applied to the
findings of studies of medium quality, and new codes added
where appropriate. The findings of the lowest quality studies were
coded using this list, but no new codes based on these findings
were created.
Second, descriptive themes were produced by grouping codes
according to their conceptual and descriptive similarities and
given overarching labels. Third, analytical themes were generated
by considering the descriptive themes in relation to the review
objectives and identifying conceptual links across the descriptive
themes, to infer novel interpretations of the primary study
findings. Preliminary analytical themes were discussed as a
research team on multiple occasions, to reach agreement on the
most appropriate thematic structure.
RESULTS
Search results
Electronic searches identified 6877 articles (Fig. 1). In total, eight
papers, describing seven studies, were eligible for inclusion
(Table 1).
Study characteristics
All papers were published between 2001 and 2015 (Table 2). The
eight papers were from six countries: the UK (k= 2), the USA (k=
2), Hong Kong (k= 1), Denmark (k= 1), Norway (k= 1) and
Sweden (k= 1). The two papers from the UK were based on the
data collected by one study and used different analysis methods
to answer different research questions.7,31 The primary focus of all
studies was to explore women’s perspectives on and experiences
of having a false-positive breast screening test result. One study
also sought to understand the views of women with false-positive
screening test results with the specific purpose of developing
improved breast screening services.31
The women included in the primary studies were interviewed at
varying time points following screening, ranging from a few days
to over 12 years. One study interviewed eight women at two time































n = 5 included women with
breast cancer in sample
and findings were
inseparable
n = 3 not clear whether
women had false-positive
result, positive result or
breast cancer
n = 3 ineligible analysis of
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themes)
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only
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21 full-text articles
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eligible articles
Fig. 1 PRISMA flow diagram of study inclusion process
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attending screening assessment and again after the interviewees
received their false-positive breast screening test result.32 Two
participants were diagnosed with cancer. The findings from the
first and second interview data were separately reported. Only
findings from the first interview were synthesised in the present
review.
Quality appraisal results
The included studies were of mixed quality, ranging from
moderately good7 to poor33,34 (Supplementary Materials 4). There
was often little to no evidence that the authors considered their
own role, potential bias or influence in the research design and
with participants. Most studies had data analysis issues (e.g.
insufficient methodological detail and issues of rigour and
trustworthiness). None of the studies adequately reported the
study’s ontological and epistemological underpinnings. Two
studies were rated as particularly low quality,33,34 bringing the
trustworthiness of their findings into question. As a result, no new
codes were developed based on the data extracted from these
studies. The data were used to support the codes generated by
analysing the findings of higher quality studies.
Results of the synthesis
Eight descriptive themes were generated: perceptions of health,
state of uncertainty, making sense of the situation, being ‘looked
after’ by the system, complying with the screening programme,
breast cancer specific worries and anxieties, attitudes towards
screening and re-attendance, and reappraisal of life. From these
descriptive themes, three analytical themes were produced:
expectations for their health and screening experience, living with
uncertainty, and restoration of the healthy self. Supplementary
Materials 5 shows a thematic map of the findings. Author quotes
from the primary studies are indicated by use of italics and
participant quotes by quotation marks.
Expectations for their health and screening experience
At the point of invitation, women seemed to perceive the
screening programme as a service for healthy women; as a means
to prove and evidence their good health, rather than to diagnose
breast cancer. Women felt at low, or no, risk of cancer, and
willingly accepted the invitation to be screened: “When I got the
first invitation to a mammography screening I was looking forward
to it very much because I don’t have any illnesses. I’m fit and
healthy, nothing is wrong with me, and I haven’t felt any changes
or strange sensations at all.”8
Women appeared to unquestioningly comply with the screen-
ing invitation; attending screening was seen as a conscientious
and responsible action. They perceived screening as part of their
health maintenance routine7 and as an opportunity to be a health
responsible citizen.8 Lindberg et al.8 noted: they [women] did not
recall having read the enclosed information leaflet, indicating that
participation was not a result of an informed, rational choice based
on the information provided on the benefits and harms of screening.
They described welcoming the invitation to be screened and, in
some cases, were relieved to be invited: “There was a relief that I
was now in the system in a way that meant that I would have
regular mammograms.”7 Being ‘in the system’ offered women a
sense of security and comfort, and they perceived that the role of
the service was to look after women: “Someone is keeping an eye
on you. Then you can feel safe knowing that nothing is wrong
with you.”8 Bond et al.7 interpreted this as a handing of
responsibility for their health, in some measure, over to the
NHS, wherein women became passive partakers of assessment
procedures.31
Having understood screening as an opportunity to receive a
clean bill of health, women did not expect to be recalled and
described feeling surprised and shocked as a result. They felt they
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the accompanying uncertainty in the interim. Having opted into
the process of breast cancer diagnostics, they experienced that
there was no way out other than awaiting the follow-up
examination.32 However, while some described a need for more
consultation and shared decision-making, they also reported
feeling disempowered by the assessment process: “I think when
you’re in the middle of it, you just go along with whatever’s being
told… there could have been, uh, more consultation maybe at the
beginning of things… so… and I’d have probably still have gone
along with it, [biopsy] ‘cause I don’t think I felt empowered not
to.”31 Women expressed a desire for greater involvement in
decisions about how to proceed in assessment and requested
choice in the following decisions: (i) a repeat mammogram or
‘watchful waiting’ in place of a biopsy for lesions thought to be
benign, (ii) whether to receive biopsy results over the telephone or
by post and (iii) a follow-up mammogram for reassurance.31
At screening assessment, some women felt well cared-for and
supported by the service’s healthcare professionals (HCPs). Other
women, in contrast to their expectations, perceived the service
and HCPs to be task-focused rather than person-focused: “Some-
times I feel like you been herded around like old cattle, you know,
like from one room, then another. And at that particular time
when you’re put into a room nothing is really explained to you.”34
It may be the case that women have implicit expectations,
which are set in part by the screening service. As Bond et al.7
explained: this passivity may be a consequence of the UK
programme where the initiative is taken by the NHSBSP who send
eligible women an appointment. The inference is that decisions
regarding when and where a screening appointment takes place
is decided for eligible women by the programme and
thus requires no ‘active part’ from the women, to organise or
maintain participation in the service. Thus, the programme
structure may set a tone for how women subsequently engage
with the service.
Living with uncertainty
Within and between studies, there was variation in women’s
responses to receiving a recall letter, from nonchalance to extreme
fear.7 Many women reported feeling thrown into a period of
uncertainty that was stressful and difficult to live with: “There was
a lot of stress. I was stressed out not knowing what it was, and
then being too scared to find out what it was and thinking the
worse. That it would be cancer.”34 The strain of the uncertainty
came from: “Just the not knowing, I think. It’s probably just the
space in between getting the letter and having the appointment,
there’s a space where you… your mind, obviously, is going to play
tricks on you and, you know, what if this and that and anxiety.
That would have been the worst time.”7 As Bolejko et al.5
described: Being in a state of uncertainty, such as not knowing the
diagnosis when waiting for examination results, was seemingly
unbearable.
Women felt that they were ‘in limbo’: they [women] remembered
that they experienced time as passing slowly, as they waited for the
diagnostic procedures and final result.8 For many, this waiting
period was characterised by intrusive thoughts and worries about
their screening assessment, receiving their results and the
possibility of having breast cancer. In all studies, there were
women who assumed ‘the worst’ on receipt of a recall letter: “I was
just pretty terrified. I mean, my initial thought was ‘Oh, I have
breast cancer!’”35 Bond et al.7 reported: her self-belief had changed
from being a healthy woman to a breast cancer patient in the time it
took to read the letter. Many women reported a fear of breast
cancer; they worried about the unknown and potentially
catastrophic consequences of having cancer and associated the
disease with death: “I was afraid it was cancer. That’s all I could
think about. He saw some abnormal findings and made me come
in for the second mammogram… I think it [cancer] is a death
sentence.”34
In the absence of concrete answers, women described anxieties
interlaced with coping and attempts to think positively, including
looking for reassurance and signs of hope. Some reported an
initial fear of having cancer, followed by attempts to be rational
and realistic about their risk: “I think about it of course… but I’m
not really worried yet. I know things can happen, but at the same
time I feel that I need facts to relate to before I really start to
worry.”32 Some attributed the reason for their recall to potential
external factors, such as a fault with the mammography
equipment.7 Table 3 presents additional examples of cues in
women’s experiences that were interpreted as reassuring or
worrying, before their false-positive screening test result (see
Supplementary Materials 6 for contextual detail and supporting
evidence from the included studies).
Restoration of the healthy self
Women described feeling great relief when they received their
false-positive screening test result, resolving their uncertainty and
marking an end to their distress: “I came out feeling great… it’s
quite intense, um, so great feeling of relief, yes, and slightly
drained as well feeling [laughs], because it is very, yeah, very
tense… I was too dazed anyway, to be honest, to take it all in”.7
Some women described the experience as “a turning point”8 and a
“wake up call”35 and expressed gratitude and appreciation of life,
and of being in good health. For some women, the experience
appeared to be life-affirming and prompted self-reflection: “Wow,
this is simply amazing! Now I really have to start leading a healthy
lifestyle, and I also have to be a better and nicer person.”8
Generally, their false-positive screening test result reassured
women and restored their perception of being in good health.
However, their result was understood in terms of a narrow escape
from cancer, rather than an inherent limitation of screening. On
the whole, women believed their results were accurate. Some
reported feeling particularly reassured when HCPs explained their
result to them clearly: “He was ever so… really thorough, I’ve got
to say, really put my mind at rest… explained everything to me
from start to finish, … and did it in a way… not condescending
way, he explained it in a real clear and concise manner, yeah,
absolutely brilliant.”31
However, others received inconsistent, unclear or inadequate
explanations from HCPs of the reason for their recall and result: “I
feel confused about what he said to me and he didn’t really
answer my questions.”33 Unclear explanations left women with
residual worries, unanswered questions and feelings of insecurity
about their health, contributing to lasting uncertainty about being
free of cancer, e.g. ambiguous explanations: “She [consultant] said
there was a shadow there, but it wasn’t anything to worry about
and [I’m] actually thinking, ‘what is that shadow?’ I don’t think that
Table 3. Signs that women interpreted and analysed to gauge their
breast cancer risk
Sign
Their previous screening experiences.
The screening experiences of friends and family.
The presence or absence of a family history of breast cancer.
The wording of the recall letter.
The risk estimates provided in the recall letter.
The location of their screening assessment.
The turnaround time between their recall letter and screening
assessment.
The communication with and between HCPs.
The image of their lesion.
Breast self-examination.
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was ever really quite resolved… at the back of my mind I always
thought, ‘I wonder what that shadow was’.”7 Consequently, Bond
et al.31 noted: there was evidence of an unmet need for information
and reassurance that could have been given by a CNS [Clinical Nurse
Specialist] being available, and known to be available, after as well
as before assessment.
Despite the stress of their experience, women maintained that
screening is important and of value and were willing to attend
future screening appointments. However, fear of developing
breast cancer was often underlying comments regarding future
screening. Some women expressed a desire for shorter intervals
between screenings: “I thought ‘can you just see me in a year’s
time, just tell me that in years’ time, it’s all OK in a year’s time’?”31
and “I’m not quite satisfied because he asked me to have
mammogram every 2 years but I think it’s not enough. What if
there’s something wrong again 1 year later?”33 This was
particularly the case for those women who experienced lasting
uncertainty about being free of cancer, representing a wish for
more (and more frequent) reassurance: “I think the fact that you’ve
been faced with the possibility that something didn’t look quite
right, you’re not quite sure what it was that didn’t look quite right,
um, and maybe a screening a year down the line would have
been, um, something to… to, you know, relieve any nerves.”31
Subsequent screenings presented an opportunity to resolve any
lingering doubts about their false-positive screening test result.
Some wanted the programme to be extended indefinitely: “I’d
want to continue, if I was allowed. Until the day I die. Yes, that’s
what I’d prefer.”8
Some women expressed more complex attitudes towards re-
attendance. For example, some alluded to the decision as being a
‘head versus heart’ dilemma, due to an increased awareness of
their susceptibility to breast cancer: “Actually, I don’t want to go
for any more mammography, but common sense tells me to;
emotionally, I’d much prefer not having to go. I’ve always thought
that I couldn’t get BC [breast cancer], but now, common sense tells
me otherwise of course.”5 Some women described feeling
motivated to re-attend because they understood that catching
early-stage breast cancer improves their chances of treatment
success. Some authors reported on the ‘catch-22’ of screening:
women indicated that screening gave them reassurance and
evidence that they were healthy while at the same time raising
their anxiety about breast cancer.8 Few women explicitly voiced
this issue; one woman expressed hesitations about whether she
would actively re-attend when she was no longer in the eligible
age-range for screening. She was unsure whether the potential
distress of another false-positive screening test result would be
worth it, to know she was free of cancer.7
DISCUSSION
Overview of findings
Three analytic themes were developed to capture how women
experience a false-positive screening test result. Women com-
pliantly accepted their screening invitation, keen to have their
good health confirmed to them. They were therefore surprised to
be recalled and felt compelled to undergo the additional tests.
Some women expressed a desire for greater consultation with and
support from HCPs regarding their diagnostic options at screening
assessment. Overall, women experienced significant stress and a
time of high uncertainty. During this time, women described
strenuous efforts to understand the reason for their recall and the
likelihood of having breast cancer. Such acts (e.g. internalising the
experiences of others and scrutinising the wording of recall letters
and conversations with HCPs) were reassuring for some but
produced further worry for others. Seeking more information was
often an active process of interpreting and overanalysing every
related message. Receiving the false-positive screening test result
generally brought women great relief. However, inadequate
explanations from HCPs left some women in doubt about the
circumstances of their false-positive screening test result and their
health. Some women felt positive about re-attending screening,
whereas others saw it as a necessary responsibility, but one they
did not relish, and others wanted more frequent reassurance.
Relevance to existing literature
Previous research indicates that having a false-positive screening
test result can lead to short- and longer-term breast cancer-related
worry.6,9 In support, this review found that women expressed a
number of worries related to breast cancer, which were felt before
their screening assessment and beyond their false-positive
screening test result. The present review also offers novel insight:
women’s intentions to re-attend appeared to be linked to
seemingly new concerns about their breast cancer risk and
lingering doubts about their false-positive screening test result.
Moreover, the findings suggest that the structure of breast
screening programmes engenders passive participation from
women who are seeking a certificate of good health. Of note,
this notion was particularly prominent in the findings from the
European studies, where women are routinely invited to screen-
ing, but not in the findings from the North American studies,
where participation in screening is ‘opt-in’. Being recalled and
receiving a false-positive screening test result challenges their
beliefs about their health and explains why worry is so present for
these women. It is possible that the degree of breast cancer-
related worry may be poorly captured by quantitative measures,
given its prevalence in these qualitative studies. It is also possible
that women who have experienced significant worry due to a
false-positive screening test result are more likely to participate in
related research.
Strength and limitations
Explicit, systematic and reproducible methods were used to
identify eligible studies, including relevant grey or unpublished
literature, and a thorough and comprehensive quality appraisal
was conducted. Thematic synthesis was conducted according to
published methodological guidelines. The review protocol was
registered on PROSPERO and adheres to PRISMA and ENTREQ
reporting standards. This review is the first systematic review and
thematic synthesis of women’s experiences of having a false-
positive breast screening result and has identified a number of
directions for future research.
The review has some limitations. Only English language studies
were included. The synthesis relied on the primary study authors’
interpretations and published quotes and it not possible to know
how representative these are of the data as a whole, which may
be problematic as the primary studies were of mixed quality. It
should be noted that the data synthesised from Solbjor et al.32
were of women interviewed between receiving their recall letter
and attending screening assessment. Therefore, this data pertain
to the experience of being recalled for an inconclusive screening,
not specifically to the receipt of a false-positive screening test
result. However, there did not appear to be any substantial
differences between women’s experiences reported by this study
compared with others. Two of the included studies5,8 purposively
sampled women who showed evidence of breast cancer-related
worry indicated by scores on the Consequences of Screening in
Breast Cancer questionnaire.36 It is likely that the views of women
who were less negatively affected by their experience are
underrepresented in these studies, and possibly in the overall
review findings.
Implications for practice
The findings have implications for the sensitive care of women who
have been recalled. It would be helpful for screening units to be
better prepared to deal with the significant distress and uncertainty
felt by women. Current practice guidelines in the UK advise that the
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availability of a clinical nurse specialist (CNS) at screening assessment
would provide a vital source of support for women, helping them to
cope with the uncertainty of the situation and to answer any
questions they may have about the assessment process.37 All leaflets
and letters sent to women recalled for further investigations should
detail how they can contact a CNS for information and support.
Furthermore, women wanted the recall letter to explain that they
could bring a friend or relative to screening assessment for support
(Supplementary Materials 6).
It is also worth considering women’s access to and engagement
with screening materials. It remains important that the provision
of screening materials by screening centres is routine and
consistent. For example, in the UK, it is current practice for
screening centres to provide women with a standardised screen-
ing information leaflet with every incident and prevalent screen-
ing invitation. However, it is not known how well women engage
with the screening materials upon each screening invitation. It
may also be important to consider whether alternative means to
access the necessary information, including in different language
translations, is possible and, if so, made clear.
Implications for research
The present findings suggest that women have preferences for
how their false-positive screening test results are communicated
to them. Women responded well to clear, thorough and
unambiguous explanations of their results, as well as the
opportunity to ask questions. In the UK, the 2016 NHS BSP
guidelines for communicating results advise that false-positive
screening test results should be given to women in person (as
opposed to by telephone or post),38 but the present findings
indicate that it is more complex than this. It is not currently known
how to best communicate false-positive screening test results,
both at screening assessment and, for those who undergo biopsy,
at the results appointment. This warrants further research,
particularly if there is the potential to reduce lasting breast
cancer-related worry by improving the communication of results.
Some women experienced lasting breast cancer-related worry,
but for how long or to what degree is unclear. There is need for
longitudinal quantitative and qualitative studies to examine the
impact of false-positive screening test results on lasting worry.
However, current quantitative measures of worry may not
adequately capture the persistent and intrusive nature of this
experience. It will be useful to collect information on, for example,
the reason for the recall, the procedures performed at screening
assessment and the nature of the false-positive screening test
result, to see whether these may be contributing factors to lasting
worry and areas for possible research intervention. Further, worry
about breast cancer may be a key motivation for screening re-
attendance. The extent to which this is the case should be
explored, as well as the reverse scenario: whether such worry could
be a deterrent to re-attendance. This may be particularly relevant
for countries observing a decline in, or wanting to increase,
screening uptake. In the UK, uptake currently stands at 71.1% of
the total number of women invited but is falling year on year.39
Given that some women engaged in self-reflection about life
and their health following their false-positive screening test result,
it may be worth exploring the extent to which women deem such
a time to be an appropriate and acceptable ‘teachable moment’,
to encourage women to make lifestyle changes to reduce their risk
of breast cancer. The results of the Promoting Early Presentation
trial provide support for the potential of teachable moments in
breast screening.40 In this study, older women attending their final
routine screening appointment received a brief intervention that
increased breast cancer awareness at three years. Further research
with the subgroup of women who have received a false-positive
breast screening test result may usefully explore whether
they would be receptive to health messages in this time. It is
plausible that attitudes could differ depending on whether their
perceptions of being in good health have been re-confirmed or
challenged without resolution.
Women’s initial decisions to attend screening did not appear to
be based on prospective ‘weighing up’ of the harms and benefits
of screening to make an informed choice, but instead on a desire
to substantiate their good health and to act conscientiously.
Moreover, women did not appear to retrospectively perceive the
reasons for having a false-positive screening test result in terms of
the inevitable limitations of screening, but as a close call with
breast cancer and, for some, a cause for lasting health concern.
When considered together, these findings have implications for
the concept of informed choice, which is explicitly encouraged by
Western healthcare systems.41 In recent years, screening pro-
grammes in Europe have made significant efforts to improve the
information that is provided to women. For example, in the UK,
the NHS BSP has revised the information leaflet sent to women
invited for screening and the letters of correspondence through-
out the process.42 However, there is no guarantee that improved
information is sufficient to impact on women’s decision-making
processes, particularly when systems are set up to reduce
choice.43 The present findings suggest that current practices
may not be resulting in decisions based on appraisal of the harms
and benefits of screening.
CONCLUSIONS
Receiving a false-positive screening test result is a stressful
experience for women, characterised by uncertainty and worry
about having breast cancer. There is the potential for worry to last,
and this may influence women’s attitudes towards future screen-
ing and be a factor in their decisions to re-attend. The way that
breast screening programmes are organised and delivered may
hinder informed decision-making. Future research could examine
how to best communicate false-positive screening test results and
the potential for this event to motivate women to adopt
behaviours that reduce their risk of breast cancer.
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